F S&P 500
5,076.00 -31.50 (-0.62%) F Dow Jones
38,606.00 -74.00 (-0.19%) F Nasdaq
17,458.00 -206.50 (-1.17%) E-mini Russell 2000 Index Futur
2,012.60 +5.80 (+0.29%) Petróleo
83.05 +0.24 (+0.29%) Oro
2,333.50 -4.90 (-0.21%)
Aethlon Medical, Inc. (AEMD)
Fuera de horario:
Aethlon Medical, Inc.
11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
United States
619 941 0360
https://www.aethlonmedical.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 15
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Guy F. Cipriani BS (Eng.), MBA | Chief Operating Officer | 347.5k | N/D | 1971 |
| Dr. Steven P. LaRosa M.D. | Chief Medical Officer | 430k | N/D | 1967 |
| Mr. James B. Frakes M.B.A. | Interim CEO, CFO, Secretary & Director | 385k | N/D | 1957 |
| Dr. Lee D. Arnold Ph.D. | Chief Scientific Officer | N/D | N/D | 1960 |
Descripción
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Aethlon Medical, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
